Antibiotics for the treatment of dysentery in children

Beatrix S Traa1, Christa L Fischer Walker, Melinda Munos

  • 1Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

Insights

Ciprofloxacin, ceftriaxone, and pivmecillinam effectively treat childhood dysentery, achieving over 99% cure rates. These World Health Organization-recommended antibiotics reduce clinical and bacteriological symptoms, likely decreasing dysentery-related mortality.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • The World Health Organization (WHO) recommends ciprofloxacin, ceftriaxone, and pivmecillinam for childhood dysentery.
  • Recent reviews on the clinical effectiveness of these antibiotics are lacking.

Purpose of the Study:

  • To review the clinical effectiveness of ciprofloxacin, ceftriaxone, and pivmecillinam for treating dysentery in children.
  • To determine the impact of these antibiotics on treatment failure, bacteriological failure, and relapse rates.

Main Methods:

  • A systematic literature review was conducted on studies involving ciprofloxacin, ceftriaxone, and pivmecillinam for childhood dysentery in developing countries.
  • Meta-analyses were performed to assess treatment outcomes, including clinical and bacteriological failure and relapse.
  • CHERG Standard Rules were applied to evaluate the effect on diarrhea mortality.

Main Results:

  • Eight studies were included in the review.
  • Treatment with ciprofloxacin, ceftriaxone, or pivmecillinam demonstrated a cure rate exceeding 99%.
  • These antibiotics were highly effective in resolving clinical and bacteriological signs of dysentery.

Conclusions:

  • The WHO-recommended antibiotics (ciprofloxacin, ceftriaxone, pivmecillinam) are effective for treating childhood dysentery.
  • These treatments significantly reduce clinical and bacteriological manifestations of dysentery.
  • The use of these antibiotics is expected to lower dysentery-associated diarrhea mortality.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...